Viewing StudyNCT06317805



Ignite Creation Date: 2024-05-06 @ 8:16 PM
Last Modification Date: 2024-10-26 @ 3:24 PM
Study NCT ID: NCT06317805
Status: RECRUITING
Last Update Posted: 2024-03-19
First Post: 2024-02-20

Brief Title: Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Sponsor: AOP Orphan Pharmaceuticals AG
Organization: AOP Orphan Pharmaceuticals AG

Conditions & Keywords Data

Conditions:
Name
Pulmonary Arterial Hypertension
Keywords:
Name View
intermediate-low risk with severe hemodynamic impairment View
intermediate-high risk View